Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Notice of intent: Strengthening the post-market surveillance and risk management of medical devices in Canada - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 141206
Later capture
Notice of intent: Strengthening the post-market surveillance and risk management of medical devices in Canada - Canada.ca
Jan 2, 2026
hc-20260101
ID 428641
updated2 sections changed
2 sections changed0 added0 removed+0 / -3 linesChange ratio: 3%
--- +++ @@ -1,6 +1,4 @@ Notice of intent: Strengthening the post-market surveillance and risk management of medical devices in Canada-From:-Health Canada This Notice of Intent is to inform stakeholders, notably manufacturers and importers of medical devices, of our intent to propose regulatory changes to strengthen the post-market surveillance and risk management of medical devices in Canada. This proposal is part of the project, Strengthening the use of real-world evidence and regulations for medical devices@@ -44,5 +42,4 @@ Marketed Health Products Directorate, Health Products and Food Branch, Health Canada . Page details-Date modified: 2018-04-10